Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3927]
News [11447]
Articles [47]
Editorials [10]
Conferences [200]
elearning [4]
Managing the treatment of NSCLC patients during the COVID-19 pandemic (DE)
Dr Giuseppe Giaccone, Dr Marina Garassino
Managing the treatment of NSCLC patients during the COVID-19 pandemic (DE) ( Dr Giuseppe Giaccone, Dr Marina Garassino )
2 Mar 2021
Managing the treatment of NSCLC patients during the COVID-19 pandemic (FR)
Dr Giuseppe Giaccone, Dr Marina Garassino
Managing the treatment of NSCLC patients during the COVID-19 pandemic (FR) ( Dr Giuseppe Giaccone, Dr Marina Garassino )
2 Mar 2021
Reducing the risk of contracting COVID-19 in patients with NSCLC (IT)
Dr Giuseppe Giaccone, Dr Neal Navani, Professor Eric Lim
Reducing the risk of contracting COVID-19 in patients with NSCLC (IT) ( Dr Giuseppe Giaccone, Dr Neal Navani, Professor Eric Lim )
2 Mar 2021
Reducing the risk of contracting COVID-19 in patients with NSCLC (DE)
Dr Giuseppe Giaccone, Dr Neal Navani, Professor Eric Lim
Reducing the risk of contracting COVID-19 in patients with NSCLC (DE) ( Dr Giuseppe Giaccone, Dr Neal Navani, Professor Eric Lim )
2 Mar 2021
Reducing the risk of contracting COVID-19 in patients with NSCLC (FR)
Dr Giuseppe Giaccone, Dr Neal Navani, Professor Eric Lim
Reducing the risk of contracting COVID-19 in patients with NSCLC (FR) ( Dr Giuseppe Giaccone, Dr Neal Navani, Professor Eric Lim )
2 Mar 2021
Reducing the risk of contracting COVID-19 in patients with NSCLC (ES)
Dr Giuseppe Giaccone, Dr Neal Navani, Professor Eric Lim
Reducing the risk of contracting COVID-19 in patients with NSCLC (ES) ( Dr Giuseppe Giaccone, Dr Neal Navani, Professor Eric Lim )
2 Mar 2021
Promise of personalised medicine for patients with prostate cancer
Prof Eleni Efstathiou, Prof Alicia Morgans, Prof Karim Fizazi and Prof Gerhardt...
Promise of personalised medicine for patients with prostate cancer ( Prof Eleni Efstathiou, Prof Alicia Morgans, Prof Karim Fizazi and Prof Gerhardt Attard )
26 Feb 2021
Cabozantinib most effective treatment for metastatic papillary kidney cancer
Dr Sumanta Pal - City of Hope, Duarte, USA
Cabozantinib most effective treatment for metastatic papillary kidney cancer ( Dr Sumanta Pal - City of Hope, Duarte, USA )
26 Feb 2021
Oral HIF-2 α inhibitor MK-6482 in patients with advanced clear cell renal cell...
Dr Todd Michael Bauer - Sarah Cannon Research Institute and Tennessee Oncology...
Oral HIF-2 α inhibitor MK-6482 in patients with advanced clear cell renal cell carcinoma ( Dr Todd Michael Bauer - Sarah Cannon Research Institute and Tennessee Oncology, Nashville, USA )
26 Feb 2021
SEMS trial: result of a prospective, multi-institutional phase II clinical...
Dr Sia Daneshmand - University of Southern California, Los Angeles, USA
SEMS trial: result of a prospective, multi-institutional phase II clinical trial of surgery in early metastatic seminoma ( Dr Sia Daneshmand - University of Southern California, Los Angeles, USA )
24 Feb 2021
Sequencing endocrine treatment in metastatic luminal breast cancer and...
Prof Hope Rugo - University of California San Francisco, San Francisco, USA
Sequencing endocrine treatment in metastatic luminal breast cancer and alpelisib for treatment of metastatic BC ( Prof Hope Rugo - University of California San Francisco, San Francisco, USA )
24 Feb 2021
Latest developments in the treatment of mRCC
Prof Javier Puente, Prof Jens Bedke, Prof James Larkin and Prof Viktor Grünwald
Latest developments in the treatment of mRCC ( Prof Javier Puente, Prof Jens Bedke, Prof James Larkin and Prof Viktor Grünwald )
24 Feb 2021

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation